Allan Young

On the 26th March 2015, following a previous post by Hole Ousia, the Royal College of Psychiatrists stated that it “‏is committed to our Conflicts of Interest policy.” principles-of-rcpsychThis policy advises that:cr148-guidance1and that:cr148-guidance3Dr Ben Goldacre in his book “Bad Pharma” suggested that:008This is advice I have tried to follow, but have found that it is much harder than I realised. Ben Goldacre also gave this advice:007I have written to the Royal College of Psychiatrists for a number of years now as I have concerns that extant College Guidance is not being followed. Recently the President of the Royal College of Psychiatrists reassured me that “our team are on the case”. 

Here are the twenty members of the Organising Committee for the forthcoming International Congress in Birmingham. The linked biographies demonstrate that 19 out of 20 have so far not provided any declarations of interest.  At the same time there appears to have been no difficulty in offering sponsorship opportunities in advance of the conference.Organising Committtee International congress 2015Here is the view of the Editor of the BMJ this time last year. A year on and it appears that there is still a need to hold the applause.002Through research for my petition to the Scottish Government for a Sunshine Act I have collected evidence that fully supports Dr McCartney’s claim that, one way or another, “doctors’ education is paid for almost exclusively by industry”012Dr Ben Goldacre is of the same view.KONICA MINOLTA DIGITAL CAMERAThis is the Royal College of Psychiatrists response to the Association of the British Pharmaceutical Industry (ABPI) “Central Platform” which intends to set up a central, open-access register of payments. However any healthcare worker or academic can simply opt out of disclosing any payments on this registeravoid some ofIn recent social media correspondence with the President of the Royal College of Psychiatrists, Dr Ben Goldacre‏ made a series of comments:

“Surely the problem here is the College calling this a problem of the past while failing to implement basic COI transparency? It’s such a dull ancient thing to have to gripe about.”

“I’m surprised that the declarations that have been made aren’t publicly posted?”

“I am very concerned about the reputational consequences for the profession of casual false reassurance on these issues.”

“I really wish the Royal College of Psychiatrists would show some leadership and do Conflict of Interest declaration properly. Not hard, happy to help. It’s unnecessary and embarrassing to be resistant on this issue, we need to be seen to be clean by our patients.”

The President of the Royal College of Psychiatrists replied: “Give us a break Ben. We are chasing and everyone speaking will do so with a full COI. Which will largely be empty”006Unless we have transparency it is impossible for any of us to know who might be paid to educate us. We know in one year that the pharmaceutical Industry paid £40 million to healthcare workers in the UK.

Last year at a Royal College of Psychiatrists Conference, one speaker was Professor Allan Young. Professor Young’s declarations can be accessed from the webpage of the Psychopharmacology Committee of which he is currently chair.Prof Allan Young, ChairBelow is Professor Young’s “bio” as an organiser for the International Congress. As is the case for 95% of the organising committee, this does not yet include the declarations above:Prof Allan Young as organiser of RCPsych Conf

This is a post that I never wanted to write. I should not have had to. This is a governance issue. It is the Royal College of Psychiatrists who should be ensuring that their policy CR148 is being followed.

We need our College to lead on transparency otherwise we risk a dark “mark” which may be “exceptionally” difficult to rub off.

This letter has been published in the current edition of The BMJ:Quetiapine adverse reactions

Reading this letter my thoughts returned to a lecture given by Professor Allan Young at a Royal College of Psychiatrists, CPD-approved conference, in September 2014:Prof-Allan-Young2

Professor Allan Young gave no declarations of interest in his speaker biography:Outline of conference 26 Sept 14

Professor Allan Young’s speaker biography demonstrates that he is a “key opinion leader”:Prof-Allan-Young1

At the start of his talk Professor Allan Young put up this slide of his declarations of interest. Professor Allan Young did not talk through his declarations and the slide was not up long enough for the audience to read it through:

Prof Allan Young declarations 26-9-14

I recorded these quotes made by Professor Allan Young as given by him on 26 Sept 2014:

“For those of you who watch Panorama I do not give my consent for you to film this”

McQueen, 2011 “They missed out my trial” [Embolden trial]


NICE, for not taking it into account at all [Embolden trial] is rather questionable”

“Quetiapine as a mood stabiliser is the Holy Grail for Bipolar Depression” commenting on work “adapted from Peters”:

“Major Depressive Disorder (“MDD”) will generally end up as Bipolar Disorder”

“A huge number of ‘bipolars’ are missed”

“SParCLE study demonstrated that Lithium is slower than Quetiapine”

Professor Allan Young’s “Key Points slide” for “the pharmacological management of Bipolar Depression”P1030863

The forthcoming 52nd Maudsley debate. The motion is “This house believes that long term use of psychiatric medications is causing more harm than good”. One of those arguing against the motion is Professor Allan Young

52nd Maudsley debate 2015

The following MSc is advertised in PROGRESS in Neurology and Psychiatry, vol 21, issue 2, 2017: